Julie Randall shares about life after cancer at Providence Creating Hope Dinner. Learn more ›
We offer world-class care for patients with benign and malignant tumors of the oral cavity (mouth), tongue, pharynx (throat), larynx (voice box), nose, paranasal sinuses, salivary glands and thyroid gland, as well as tumors at the skull base.
The complex procedure, known as a “Jaw in a Day,” has been performed in only a few highly specialized centers in the world. Smith’s procedure, performed in August at Providence St. Vincent Medical...
In 2005, Becky Roth's dentist discovered a white spot on her tongue. It was benign, but five years later another spot led to the discovery of a tumor at the base of her tongue and jaw.
In a powerful speech to a packed house, Becky Roth spoke emotionally about the cancer that changed, but didn’t claim, her life. And, despite losing two leg bones used for her jaw reconstruction – and against...
A recent assessment of the first 170 throat-cancer patients treated with transoral robotic surgery followed by risk-adapted adjuvant therapy at Providence Cancer Institute offers compelling evidence in favor of this new...
Many clinical trials are open only to patients with metastatic disease. One of the translational research goals of the Providence Head and Neck Cancer Program is to bring immunotherapy into treatment earlier.
Adoptive T-cell transfer therapy is emerging as one of the most effective treatments to date for people with advanced melanoma. Now this treatment is available to patients with advanced or recurrent head and neck cancers...